Annual ROE
-7.26%
+94.94%+92.90%
December 31, 2023
Summary
- As of February 8, 2025, MLTX annual return on equity is -7.26%, with the most recent change of +94.94% (+92.90%) on December 31, 2023.
- MLTX annual ROE is now at all-time high.
Performance
MLTX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-15.78%
-4.73%-42.81%
September 30, 2024
Summary
- As of February 8, 2025, MLTX quarterly return on equity is -15.78%, with the most recent change of -4.73% (-42.81%) on September 30, 2024.
- Over the past year, MLTX quarterly ROE has dropped by -4.73% (-42.81%).
- MLTX quarterly ROE is now -103.35% below its all-time high of 471.05%, reached on March 31, 2022.
Performance
MLTX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
MLTX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +92.9% | -42.8% |
| 3 y3 years | - | -104.7% |
| 5 y5 years | - | -104.7% |
MLTX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +92.9% | -103.3% | +88.1% |
| 5 y | 5-year | at high | +92.9% | -103.3% | +88.1% |
| alltime | all time | at high | +92.9% | -103.3% | +88.1% |
MoonLake Immunotherapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -15.78%(+42.8%) |
| Jun 2024 | - | -11.05%(+32.7%) |
| Mar 2024 | - | -8.33%(-16.0%) |
| Dec 2023 | -7.26% | -9.92%(-45.4%) |
| Sep 2023 | - | -18.17%(-37.7%) |
| Jun 2023 | - | -29.16%(-68.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | -92.22%(-6.6%) |
| Dec 2022 | -102.20% | -98.78%(-7.4%) |
| Sep 2022 | - | -106.70%(-19.3%) |
| Jun 2022 | - | -132.21%(-128.1%) |
| Mar 2022 | - | 471.05%(+40.7%) |
| Dec 2021 | - | 334.68% |
FAQ
- What is MoonLake Immunotherapeutics annual return on equity?
- What is the all time high annual ROE for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics annual ROE year-on-year change?
- What is MoonLake Immunotherapeutics quarterly return on equity?
- What is the all time high quarterly ROE for MoonLake Immunotherapeutics?
- What is MoonLake Immunotherapeutics quarterly ROE year-on-year change?
What is MoonLake Immunotherapeutics annual return on equity?
The current annual ROE of MLTX is -7.26%
What is the all time high annual ROE for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high annual return on equity is -7.26%
What is MoonLake Immunotherapeutics annual ROE year-on-year change?
Over the past year, MLTX annual return on equity has changed by +94.94% (+92.90%)
What is MoonLake Immunotherapeutics quarterly return on equity?
The current quarterly ROE of MLTX is -15.78%
What is the all time high quarterly ROE for MoonLake Immunotherapeutics?
MoonLake Immunotherapeutics all-time high quarterly return on equity is 471.05%
What is MoonLake Immunotherapeutics quarterly ROE year-on-year change?
Over the past year, MLTX quarterly return on equity has changed by -4.73% (-42.81%)